Compounds > exp3174
Page last updated: 2024-09-02

exp3174 and vildagliptin

exp3174 has been researched along with vildagliptin in 1 studies

Compound Research Comparison

Studies
(exp3174)		Trials
(exp3174)		Recent Studies (post-2010)
(exp3174)		Studies
(vildagliptin)		Trials
(vildagliptin)		Recent Studies (post-2010) (vildagliptin)
2362943793186566

Protein Interaction Comparison

ProteinTaxonomyexp3174 (IC50)vildagliptin (IC50)
Dipeptidyl peptidase 9Bos taurus (cattle)0.68
Dipeptidyl peptidase IVPorphyromonas gingivalis1.3
Dipeptidyl peptidase 4Homo sapiens (human)0.1496
Dipeptidyl peptidase 4Mus musculus (house mouse)0.051
Prolyl endopeptidase FAPHomo sapiens (human)2.497
Dipeptidyl peptidase 8Homo sapiens (human)3.0627
Dipeptidyl peptidase 9Homo sapiens (human)0.4224
Dipeptidyl peptidase 2Homo sapiens (human)0.051

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benachour, N; Vanderheyden, PML1

Reviews

1 review(s) available for exp3174 and vildagliptin

ArticleYear
Influence of the cellular environment on ligand binding kinetics at membrane-bound targets.
    Bioorganic & medicinal chemistry letters, 2017, 08-15, Volume: 27, Issue:16

    Topics: Angiotensin II Type 1 Receptor Blockers; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Humans; Kinetics; Ligands; Protein Binding; Receptor, Angiotensin, Type 1; Receptors, Cell Surface; Signal Transduction

2017